Opportunities and challenges for T cell-based influenza vaccines

TR Mosmann, AJ McMichael, A LeVert… - Nature Reviews …, 2024 - nature.com
Vaccination remains our main defence against influenza, which causes substantial annual
mortality and poses a serious pandemic threat. Influenza virus evades immunity by rapidly …

The fight against poliovirus is not over

CJ Mbani, MP Nekoua, D Moukassa, D Hober - Microorganisms, 2023 - mdpi.com
Poliovirus (PV), the virus that causes both acute poliomyelitis and post-polio syndrome, is
classified within the Enterovirus C species, and there are three wild PV serotypes: WPV1 …

[HTML][HTML] Progress toward poliomyelitis eradication—worldwide, January 2021–March 2023

SE Lee - MMWR. Morbidity and mortality weekly report, 2023 - cdc.gov
In 2022, Malawi and Mozambique reported WPV1 cases linked to a Pakistan strain, the first
WPV1 cases in the African region since 2016. During 2022 and 2023, Afghanistan and …

[HTML][HTML] Update on vaccine-derived poliovirus outbreaks—worldwide, January 2021–December 2022

JP Bigouette - MMWR. Morbidity and Mortality Weekly Report, 2023 - cdc.gov
During January 2021–December 2022, 76 cVDPV type 2 outbreaks occurred in 42
countries. Since 2020, the numbers of paralytic cases and new emergences have declined …

[HTML][HTML] Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022

NS Zuckerman, I Bar-Or, D Sofer, E Bucris… - …, 2022 - eurosurveillance.org
We report an emergence and increase in poliovirus type 2 detection via routine wastewater
surveillance in three non-overlapping regions in the Jerusalem region, Israel, between April …

Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised …

AL Wilkinson, K Zaman, M Hoque… - The Lancet Infectious …, 2023 - thelancet.com
Background Novel oral poliovirus vaccine type 2 (nOPV2) was developed by modifying the
Sabin strain to increase genetic stability and reduce risk of seeding new circulating vaccine …

Comprehensive profiling of neutralizing polyclonal sera targeting coxsackievirus B3

B Álvarez-Rodríguez, J Buceta, R Geller - Nature Communications, 2023 - nature.com
Despite their fundamental role in resolving viral infections, our understanding of how
polyclonal neutralizing antibody responses target non-enveloped viruses remains limited …

[HTML][HTML] Progress Toward Poliomyelitis Eradication—Afghanistan, January 2022–June 2023

A Bjork - MMWR. Morbidity and Mortality Weekly Report, 2023 - cdc.gov
Abstract When the Global Polio Eradication Initiative began in 1988, wild poliovirus (WPV)
transmission was reported in 125 countries. Since 2017, Afghanistan and Pakistan remain …

Worst‐case scenarios: Modeling uncontrolled type 2 polio transmission

DA Kalkowska, E Wiesen, SGF Wassilak… - Risk …, 2024 - Wiley Online Library
Abstract In May 2016, the Global Polio Eradication Initiative (GPEI) coordinated the
cessation of all use of type 2 oral poliovirus vaccine (OPV2), except for emergency outbreak …

[HTML][HTML] Progress toward poliomyelitis eradication―Afghanistan, January 2021–September 2022

A Mohamed - MMWR. Morbidity and Mortality Weekly Report, 2022 - cdc.gov
Two WPV1 cases had been reported in 2022 as of September 30, compared with one case
during the same period in 2021. No type 2 circulating vaccine-derived poliovirus was …